Skip to main content
Erschienen in: Journal of Cardiovascular Translational Research 5/2019

06.03.2019 | Original Article

Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease

verfasst von: Jan Fiedler, Da-Hee Park, Lisa Hobuß, Parnian Kalbasi Anaraki, Angelika Pfanne, Annette Just, Saskia Mitzka, Inna Dumler, Frank Weidemann, Andres Hilfiker, Thomas Thum

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Calcification of aortic valves leads to aortic stenosis mainly in elderly individuals, but the underlying molecular mechanisms are still not understood. Here, we studied microRNA (miR, miRNA) expression and function in healthy and stenotic human aortic valves. We identified miR-21, miR-24, and miR-143 to be highly upregulated in stenotic aortic valves. Using luciferase reporter systems, we found direct binding of miR-143 to the 3′UTR region of the matrix gla protein (MGP), which in turn is a key factor to sustain homeostasis in aortic valves. In subsequent experiments, we demonstrated a therapeutic potential of miRNA regulation during calcification in cardiac valvular interstitial cells. Collectively, our data provide evidence that deregulated miR expression contributes to the development of stenotic valve disease and thus form novel therapeutic opportunities of this severe cardiovascular disease.
Literatur
1.
Zurück zum Zitat Thaden, J. J., Nkomo, V. T., & Enriquez-Sarano, M. (2014). The global burden of aortic stenosis. Progress in Cardiovascular Diseases, 56, 565–571.CrossRef Thaden, J. J., Nkomo, V. T., & Enriquez-Sarano, M. (2014). The global burden of aortic stenosis. Progress in Cardiovascular Diseases, 56, 565–571.CrossRef
2.
Zurück zum Zitat Carabello, B. A. (2013). Introduction to aortic stenosis. Circulation Research, 113, 179–185.CrossRef Carabello, B. A. (2013). Introduction to aortic stenosis. Circulation Research, 113, 179–185.CrossRef
3.
Zurück zum Zitat Bach, D. S. (2011). Prevalence and characteristics of unoperated patients with severe aortic stenosis. The Journal of Heart Valve Disease, 20, 284–291.PubMed Bach, D. S. (2011). Prevalence and characteristics of unoperated patients with severe aortic stenosis. The Journal of Heart Valve Disease, 20, 284–291.PubMed
4.
Zurück zum Zitat Park, S. J., Enriquez-Sarano, M., Chang, S. A., Choi, J. O., Lee, S. C., Park, S. W., Kim, D. K., Jeon, E. S., & Oh, J. K. (2013). Hemodynamic patterns for symptomatic presentations of severe aortic stenosis. JACC: Cardiovascular Imaging, 6, 137–146.PubMed Park, S. J., Enriquez-Sarano, M., Chang, S. A., Choi, J. O., Lee, S. C., Park, S. W., Kim, D. K., Jeon, E. S., & Oh, J. K. (2013). Hemodynamic patterns for symptomatic presentations of severe aortic stenosis. JACC: Cardiovascular Imaging, 6, 137–146.PubMed
5.
Zurück zum Zitat Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Jr., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., O’Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., & American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008). 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Journal of the American College of Cardiology, 52, e1–e142. Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Jr., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., O’Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., & American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008). 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Journal of the American College of Cardiology, 52, e1–e142.
6.
Zurück zum Zitat Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell., 120, 15–20.CrossRef Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell., 120, 15–20.CrossRef
7.
Zurück zum Zitat Sheehan D, Hrapchak B (1980) Theory and practice of histotechnology. Battelle Press, Ohio; 2nd Ed: 226–227. Sheehan D, Hrapchak B (1980) Theory and practice of histotechnology. Battelle Press, Ohio; 2nd Ed: 226–227.
8.
Zurück zum Zitat Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., Castoldi, M., Soutschek, J., Koteliansky, V., Rosenwald, A., Basson, M. A., Licht, J. D., Pena, J. T., Rouhanifard, S. H., Muckenthaler, M. U., Tuschl, T., Martin, G. R., Bauersachs, J., & Engelhardt, S. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456, 980–984.CrossRef Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., Castoldi, M., Soutschek, J., Koteliansky, V., Rosenwald, A., Basson, M. A., Licht, J. D., Pena, J. T., Rouhanifard, S. H., Muckenthaler, M. U., Tuschl, T., Martin, G. R., Bauersachs, J., & Engelhardt, S. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456, 980–984.CrossRef
9.
Zurück zum Zitat Fiedler, J., Jazbutyte, V., Kirchmaier, B. C., Gupta, S. K., Lorenzen, J., Hartmann, D., Galuppo, P., Kneitz, S., Pena, J. T., Sohn-Lee, C., Loyer, X., Soutschek, J., Brand, T., Tuschl, T., Heineke, J., Martin, U., Schulte-Merker, S., Ertl, G., Engelhardt, S., Bauersachs, J., & Thum, T. (2011). MicroRNA-24 regulates vascularity after myocardial infarction. Circulation, 124, 720–730.CrossRef Fiedler, J., Jazbutyte, V., Kirchmaier, B. C., Gupta, S. K., Lorenzen, J., Hartmann, D., Galuppo, P., Kneitz, S., Pena, J. T., Sohn-Lee, C., Loyer, X., Soutschek, J., Brand, T., Tuschl, T., Heineke, J., Martin, U., Schulte-Merker, S., Ertl, G., Engelhardt, S., Bauersachs, J., & Thum, T. (2011). MicroRNA-24 regulates vascularity after myocardial infarction. Circulation, 124, 720–730.CrossRef
10.
Zurück zum Zitat Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T. H., Miano, J. M., Ivey, K. N., & Srivastava, D. (2009). miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature., 460, 705–710.CrossRef Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T. H., Miano, J. M., Ivey, K. N., & Srivastava, D. (2009). miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature., 460, 705–710.CrossRef
11.
Zurück zum Zitat Boettger, T., Beetz, N., Kostin, S., Schneider, J., Kruger, M., Hein, L., & Braun, T. (2009). Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. The Journal of Clinical Investigation, 119, 2634–2647.CrossRef Boettger, T., Beetz, N., Kostin, S., Schneider, J., Kruger, M., Hein, L., & Braun, T. (2009). Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. The Journal of Clinical Investigation, 119, 2634–2647.CrossRef
12.
Zurück zum Zitat Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., & Karsenty, G. (1997). Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature., 386, 78–81.CrossRef Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., & Karsenty, G. (1997). Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature., 386, 78–81.CrossRef
13.
Zurück zum Zitat Pillai, I. C. L., Li, S., Romay, M., Lam, L., Lu, Y., Huang, J., Dillard, N., Zemanova, M., Rubbi, L., Wang, Y., Lee, J., Xia, M., Liang, O., Xie, Y. H., Pellegrini, M., Lusis, A. J., & Deb, A. (2017). Cardiac fibroblasts adopt osteogenic fates and can be targeted to attenuate pathological heart calcification. Cell Stem Cell, 20, 218–232.e5.CrossRef Pillai, I. C. L., Li, S., Romay, M., Lam, L., Lu, Y., Huang, J., Dillard, N., Zemanova, M., Rubbi, L., Wang, Y., Lee, J., Xia, M., Liang, O., Xie, Y. H., Pellegrini, M., Lusis, A. J., & Deb, A. (2017). Cardiac fibroblasts adopt osteogenic fates and can be targeted to attenuate pathological heart calcification. Cell Stem Cell, 20, 218–232.e5.CrossRef
14.
Zurück zum Zitat Dweck, M. R., Jones, C., Joshi, N. V., Fletcher, A. M., Richardson, H., White, A., Marsden, M., Pessotto, R., Clark, J. C., Wallace, W. A., Salter, D. M., McKillop, G., van Beek, E. J., Boon, N. A., Rudd, J. H., & Newby, D. E. (2012). Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation, 125, 76–86.CrossRef Dweck, M. R., Jones, C., Joshi, N. V., Fletcher, A. M., Richardson, H., White, A., Marsden, M., Pessotto, R., Clark, J. C., Wallace, W. A., Salter, D. M., McKillop, G., van Beek, E. J., Boon, N. A., Rudd, J. H., & Newby, D. E. (2012). Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation, 125, 76–86.CrossRef
15.
Zurück zum Zitat Song, R., Fullerton, D. A., Ao, L., Zhao, K. S., & Meng, X. (2017). An epigenetic regulatory loop controls pro-osteogenic activation by TGF-beta1 or bone morphogenetic protein 2 in human aortic valve interstitial cells. The Journal of Biological Chemistry, 292, 8657–8666.CrossRef Song, R., Fullerton, D. A., Ao, L., Zhao, K. S., & Meng, X. (2017). An epigenetic regulatory loop controls pro-osteogenic activation by TGF-beta1 or bone morphogenetic protein 2 in human aortic valve interstitial cells. The Journal of Biological Chemistry, 292, 8657–8666.CrossRef
Metadaten
Titel
Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease
verfasst von
Jan Fiedler
Da-Hee Park
Lisa Hobuß
Parnian Kalbasi Anaraki
Angelika Pfanne
Annette Just
Saskia Mitzka
Inna Dumler
Frank Weidemann
Andres Hilfiker
Thomas Thum
Publikationsdatum
06.03.2019
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 5/2019
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-019-09880-7

Weitere Artikel der Ausgabe 5/2019

Journal of Cardiovascular Translational Research 5/2019 Zur Ausgabe

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.